These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

326 related items for PubMed ID: 17227317

  • 1. Non-alcoholic fatty liver disease, the metabolic syndrome and the risk of cardiovascular disease: the plot thickens.
    Targher G.
    Diabet Med; 2007 Jan; 24(1):1-6. PubMed ID: 17227317
    [Abstract] [Full Text] [Related]

  • 2. Non-alcoholic fatty liver disease and increased risk of cardiovascular disease.
    Targher G, Arcaro G.
    Atherosclerosis; 2007 Apr; 191(2):235-40. PubMed ID: 16970951
    [Abstract] [Full Text] [Related]

  • 3. Association between non-alcoholic fatty liver disease and cardiovascular disease: a first message should pass.
    Picardi A, Vespasiani-Gentilucci U.
    Am J Gastroenterol; 2008 Dec; 103(12):3036-8. PubMed ID: 18853984
    [Abstract] [Full Text] [Related]

  • 4. The role of non-alcoholic fatty liver disease in cardiovascular disease.
    Perseghin G.
    Dig Dis; 2010 Dec; 28(1):210-3. PubMed ID: 20460913
    [Abstract] [Full Text] [Related]

  • 5. Increased prevalence of cardiovascular disease in Type 2 diabetic patients with non-alcoholic fatty liver disease.
    Targher G, Bertolini L, Padovani R, Poli F, Scala L, Tessari R, Zenari L, Falezza G.
    Diabet Med; 2006 Apr; 23(4):403-9. PubMed ID: 16620269
    [Abstract] [Full Text] [Related]

  • 6. Impact of non-alcoholic fatty liver disease on accelerated metabolic complications.
    Fan JG.
    J Dig Dis; 2008 May; 9(2):63-7. PubMed ID: 18419637
    [Abstract] [Full Text] [Related]

  • 7. Relations between carotid artery wall thickness and liver histology in subjects with nonalcoholic fatty liver disease.
    Targher G, Bertolini L, Padovani R, Rodella S, Zoppini G, Zenari L, Cigolini M, Falezza G, Arcaro G.
    Diabetes Care; 2006 Jun; 29(6):1325-30. PubMed ID: 16732016
    [Abstract] [Full Text] [Related]

  • 8. Non-alcoholic fatty liver disease (NAFLD) and cardiovascular disease: an open question.
    Loria P, Lonardo A, Bellentani S, Day CP, Marchesini G, Carulli N.
    Nutr Metab Cardiovasc Dis; 2007 Nov; 17(9):684-98. PubMed ID: 17560098
    [Abstract] [Full Text] [Related]

  • 9. Recent concepts in non-alcoholic fatty liver disease.
    Adams LA, Angulo P.
    Diabet Med; 2005 Sep; 22(9):1129-33. PubMed ID: 16108837
    [Abstract] [Full Text] [Related]

  • 10. Is liver fat detrimental to vessels?: intersections in the pathogenesis of NAFLD and atherosclerosis.
    Loria P, Lonardo A, Targher G.
    Clin Sci (Lond); 2008 Jul; 115(1):1-12. PubMed ID: 19016656
    [Abstract] [Full Text] [Related]

  • 11. Nonalcoholic fatty liver disease: hepatic manifestation of obesity and the metabolic syndrome.
    Boppidi H, Daram SR.
    Postgrad Med; 2008 Jul 31; 120(2):E01-7. PubMed ID: 18654060
    [Abstract] [Full Text] [Related]

  • 12. Alanine aminotransferase as a marker of non-alcoholic fatty liver disease in relation to type 2 diabetes mellitus and cardiovascular disease.
    Schindhelm RK, Diamant M, Dekker JM, Tushuizen ME, Teerlink T, Heine RJ.
    Diabetes Metab Res Rev; 2006 Jul 31; 22(6):437-43. PubMed ID: 16832839
    [Abstract] [Full Text] [Related]

  • 13. Hepatic steatosis and vascular disease.
    Santoliquido A, Di Campli C, Miele L, Gabrieli ML, Forgione A, Zocco MA, Lupascu A, Di Giorgio A, Flore R, Pola P, Gasbarrini G, Gasbarrini A, Tondi P, Grieco A.
    Eur Rev Med Pharmacol Sci; 2005 Jul 31; 9(5):269-71. PubMed ID: 16231588
    [Abstract] [Full Text] [Related]

  • 14. What are the risk factors and settings for non-alcoholic fatty liver disease in Asia-Pacific?
    Fan JG, Saibara T, Chitturi S, Kim BI, Sung JJ, Chutaputti A, Asia-Pacific Working Party for NAFLD.
    J Gastroenterol Hepatol; 2007 Jun 31; 22(6):794-800. PubMed ID: 17498218
    [Abstract] [Full Text] [Related]

  • 15. Non-alcoholic fatty liver disease is associated with cardiovascular disease risk markers.
    Edens MA, Kuipers F, Stolk RP.
    Obes Rev; 2009 Jul 31; 10(4):412-9. PubMed ID: 19413701
    [Abstract] [Full Text] [Related]

  • 16. Current treatment of non-alcoholic fatty liver disease.
    Ahmed MH, Byrne CD.
    Diabetes Obes Metab; 2009 Mar 31; 11(3):188-95. PubMed ID: 18564173
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Metabolic syndrome, non-alcoholic fatty liver disease and hepatitis C virus: impact on disease progression and treatment response.
    Younossi ZM, McCullough AJ.
    Liver Int; 2009 Mar 31; 29 Suppl 2():3-12. PubMed ID: 19187068
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.